Phase I/II study of zotiraciclib for recurrent malignant gliomas with IDH mutations: updated results of the phase I study (SNO 2026) - Sep 9, 2026 - Abstract #CTNI-10; Pres time: Nov 13, 2026; 07:30 PM - 09:30 PM; Location: Exhibit Hall D & E; No abstract available
P1/2 data • Brain Cancer • Glioma • High Grade Glioma • Solid Tumor
|
|
Christine McGowan; Lisa Boris; Tina Pillai; Keith Schmidt; Tryston Metz; Jennifer Reyes; Faiza Khan; Martha Quezado; Liqiang Xi; Kareem Zaghloul; William Figg; Kevin Camphausen; Yuan Ying; Jing Wu
|